本次传出出售博士伦的消息，或许与博士康的当下困境密不可分。据报道，博士康现有债务为210亿美元，其中100亿美元将在2027年底前到期。然而由于博士伦是重要的创收子公司，母公司必须通过偿付能力测试，然后才能批准出售。

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

The global skincare devices market size was US$ 9 billion in 2019. The global skincare device market is forecast to reach US$ 28 billion by 2030 by growing at a compound annual growth rate (CAGR) of ...

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Shares of Bausch + Lomb (NYSE: BLCO) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company ...

The stock of eyecare company Bausch + Lomb Corp. was up 14%on Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its indebted ...

Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with significant debt, as ...

Bausch Health retained an 88 per cent shareholding in the eye care subsidiary after listing the group in 2022. But it planned ...